In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OmegaQuant's Prenatal Test Counts DHA Level To Help Prevent Premature Labor

Executive Summary

OmegaQuant's test helps expectant mothers monitor DHA levels, data that can help prevent premature labor. The kit – a blood collection card, lancet, alcohol pad, bandage and gauze pad sent to the company for analysis – could help curb problem that costs US health care industry around $6bn annually.

You may also be interested in...



Anlit adds to Omega Bites

Israel’s Anlit is looking for partners to commercialise the latest addition to its Omega Bites range of omega-3 supplements, Omega Bites Prenatal.

CHPA Rebranding Reflects Growing Device Interests In Evolving Self-Care Market

The Consumer Healthcare Products Association’s rebranding initiative – its first in 20 years – aligns the group with today’s self-care marketplace where consumer medical devices play an increasingly prominent role. It also follows “landmark legislative achievements in 2020 that will further empower consumers to practice responsible self-care,” CHPA says.

FDA's COVID-19 Naughty List Now Includes Marketers Of Copper Germ Stoppers, ‘24-Hour’ Hand Sanitizer

Warning letters issued by the US FDA on 28 May target two companies using COVID-19 and other disease-prevention claims to market purported germ-killing products, including a rub touted as 24-hour protection and a line of copper rollers and other implements to disinfect hands and personal items.

Topics

UsernamePublicRestriction

Register

PL043173

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel